INNOVATIVE PHARMACEUTICAL BIOTECH L financial statements, including revenue, expenses, profit, and loss

The total revenue of 399 for the last semiannual is 2.87 M HKD, and it's 23.10% lower compared to the previous semiannual. The net income of H2 23 is -90.28 M HKD.